Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;78(1):103-115.
doi: 10.1053/j.ajkd.2021.03.008. Epub 2021 Apr 9.

Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report From the NKF-ASN Task Force

Affiliations

Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report From the NKF-ASN Task Force

Cynthia Delgado et al. Am J Kidney Dis. 2021 Jul.

Abstract

For almost 2 decades, equations that use serum creatinine, age, sex, and race to estimate glomerular filtration rate (GFR) have included "race" as Black or non-Black. Given considerable evidence of disparities in health and health care delivery in African American communities, some regard keeping a race term in GFR equations as a practice that differentially influences access to care and kidney transplantation. Others assert that race captures important non-GFR determinants of serum creatinine and its removal from the calculation may perpetuate other disparities. The National Kidney Foundation (NKF) and American Society of Nephrology (ASN) established a task force in 2020 to reassess the inclusion of race in the estimation of GFR in the United States and its implications for diagnosis and subsequent management of patients with, or at risk for, kidney diseases. This interim report details the process, initial assessment of evidence, and values defined regarding the use of race to estimate GFR. We organized activities in phases: (1) clarify the problem and examine evidence, (2) evaluate different approaches to address use of race in GFR estimation, and (3) make recommendations. In phase 1, we constructed statements about the evidence and defined values regarding equity and disparities; race and racism; GFR measurement, estimation, and equation performance; laboratory standardization; and patient perspectives. We also identified several approaches to estimate GFR and a set of attributes to evaluate these approaches. Building on evidence and values, the attributes of alternative approaches to estimate GFR will be evaluated in the next phases and recommendations will be made.

Keywords: United States; creatinine; estimated glomerular filtration rate (eGFR); estimating equation; ethnicity; filtration marker; health care equity; health disparities; kidney disease; kidney disease diagnosis; laboratory medicine; medical decision making; patient-centered care; public health; race; race coefficient; racism; renal function; social determinants of health.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Miller WG, Jones GRD. Estimated glomerular filtration rate; laboratory implementation and current global status. Adv Chronic Kidney Dis. 2018;25:7–13. - PubMed
    1. Centers for Disease Control (CDC). Chronic Disease Surveil-lance System—United States. Accessed December 1, 2020. https://nccd.cdc.gov/CKD/default.aspx
    1. Williams ME, Chianchiano D. Medicare medical nutrition therapy: Legislative process and product. J Ren Nutr. 2002;12:1–7. - PubMed
    1. Centers for Medicare and Medicaid Services (CMS). Kidney disease education. Accessed January 4, 2021. https://www.medicare.gov/coverage/kidney-disease-education
    1. United States Renal Data System. Accessed December 1, 2020. https://www.usrds.org